Cargando…

Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.

Small cell bronchial carcinoma (SCC) xenografts with differing sensitivity to cyclophosphamide (CY) were investigated using a variety of techniques. Two xenografts (HX78 and HX88) were relatively sensitive to CY, one xenograft (HX72) was inherently resistant to CY and a fourth xenograft (HX78Cy) was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berman, R., Gusterson, B., Steel, G. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977064/ https://www.ncbi.nlm.nih.gov/pubmed/2581600

Ejemplares similares

Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.
por: Berman, R., et al.
Publicado: (1984)

Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.
por: Shorthouse, A. J., et al.
Publicado: (1982)

The response to chemotherapy of a variety of human tumour xenografts.
por: Steel, G. G., et al.
Publicado: (1983)

Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
por: Pearce, David R., et al.
Publicado: (2023)

Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour.
por: Bateman, A. E., et al.
Publicado: (1979)

The growth kinetics of xenografts of human colorectal tumours in immune deprived mice.
por: Pickard, R. G., et al.
Publicado: (1975)

Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
por: Hussein, D, et al.
Publicado: (2009)

Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
por: Brown, J. M., et al.
Publicado: (1982)

Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Evaluation of single-agent therapy in human colorectal tumour xenografts.
por: Houghton, P. J., et al.
Publicado: (1978)

Gene expression in oestrogen-dependent human breast cancer xenograft tumours.
por: Thompson, A. M., et al.
Publicado: (1990)

Differential efficacy of flavone acetic against liver versus lung metastases in a human tumour xenograft.
por: Pratesi, G., et al.
Publicado: (1991)

Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice
por: Nath, Kavindra, et al.
Publicado: (2016)

Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents
por: Colella, G, et al.
Publicado: (1999)

Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture
por: Jiang, Yanyan, et al.
Publicado: (2015)

DNA direct reversal repair and alkylating agent drug resistance
por: Gutierrez, Roberto, et al.
Publicado: (2021)

Enzyme activated alkylating agents.
por: Ball, C. R., et al.
Publicado: (1973)

Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.
por: Sundaresan, V., et al.
Publicado: (1991)

Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.
por: Ornadel, D., et al.
Publicado: (1998)

Urinary markers for exposures to alkylating or nitrosating agents.
por: Wishnok, J S, et al.
Publicado: (1993)

Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes
por: Tran, Thai Q., et al.
Publicado: (2017)

Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
por: Stanley, J. A., et al.
Publicado: (1977)

Effect of Previous Alkylating Agent Exposure on Follicle Numbers in Cryopreserved Prepubertal and Young Adult Ovarian Tissue after Long-Term Xenografting
por: Nurmio, Mirja, et al.
Publicado: (2022)

The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
por: Lartigau, E., et al.
Publicado: (1996)

Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
por: Jensen, P. B., et al.
Publicado: (1993)

The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations
por: Kulkarni, Aditya, et al.
Publicado: (2021)

Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis
por: Turkki, Riku, et al.
Publicado: (2015)

O(6)-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents
por: Walter, T, et al.
Publicado: (2015)

Proceedings: Alkylating agents as industrial carcinogens.
por: Munn, A.
Publicado: (1975)

Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance
por: Kita, Kenji, et al.
Publicado: (2019)

The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma.
por: Harrap, K. R., et al.
Publicado: (1969)

Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.
por: Kwa, H. B., et al.
Publicado: (1996)

3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.
por: Damia, G., et al.
Publicado: (1996)

Raman spectroscopy identifies radiation response in human non-small cell lung cancer xenografts
por: Harder, Samantha J., et al.
Publicado: (2016)

Chemotherapy of human breast-carcinoma xenografts.
por: Bailey, M. J., et al.
Publicado: (1980)

Effects of cytotoxic agents on TdR incorporation and growth delay in human colonic tumour xenografts.
por: Houghton, P. J., et al.
Publicado: (1977)

Influence of biogenic amines on the growth of xenografted human colorectal carcinomas.
por: Tutton, P. J., et al.
Publicado: (1979)

Chemotherapy-radiation interactions in human cervix carcinoma xenografts.
por: Tonkin, K. S., et al.
Publicado: (1988)

The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
por: Courtenay, V. D., et al.
Publicado: (1982)

Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.
por: Nowak, K., et al.
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_u75e9nfpqj2snd9eneja179u8b